Navigation Links
Genzyme Launches Cholestagel(R) in Europe
Date:10/23/2007

New Therapy Helps Lower Cholesterol in Primary Hypercholesterolemia

Patients

CAMBRIDGE, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) today announced the launch of Cholestagel(R) (colesevelam hydrochloride), Genzyme's first commercially available cardiovascular product, in Europe. Cholestagel is a new, non-absorbed, cholesterol-lowering agent aimed at treating patients with primary hypercholesterolemia who cannot meet their targeted cholesterol levels with standard therapies alone.

"Cholestagel offers patients at high risk of life-threatening cardiovascular disease a new way to manage their cholesterol," said Genzyme Senior Vice President James A. Geraghty, who oversees the company's cardiovascular activities. "Most of these high-risk patients are seen at specialized treatment centers, and the launch of Cholestagel in Europe is consistent with our efforts to provide treatments for patients with serious unmet medical needs. We intend to do so with a small and highly-focused field organization that leverages Genzyme's existing country organizations."

Developed by Genzyme, Cholestagel is a polymer in tablet form that lowers LDL (or "bad") cholesterol. It can be taken in combination with other cholesterol-lowering medications, such as statins, or alone. When combined with various statins, fibrates or ezetimibe, current standard treatments for cholesterol control, Cholestagel was shown to have an additive LDL-cholesterol lowering effect in the range of 10 to 16 percent. A post-approval study launched in August 2007 by Genzyme aims to specifically demonstrate the efficacy of Cholestagel as an add-on therapy in patients with familial hypercholeste
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. Merge launches diagnostic mammography workstation in Europe
5. Einstein Wireless launches cellular alert system
6. Logistics Health launches compliance management tool
7. UW-Madison launches new high-speed research network
8. UWM launches research foundation
9. TeraMedica launches information manager
10. GE Healthcare launches hybrid electronic record
11. Cedara launches new version of DICOM toolkit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 02, 2015 Shimadzu Scientific Instruments ... present on LCMS and marijuana analysis at the Pittcon ... 8 to 12 at the Ernest N. Morial Convention ... stop by booth 3121 to discuss laboratory challenges with ... innovative, proven products help save time, money and effort ...
(Date:3/2/2015)... Resilinc released online today ... which summarizes and analyzes nearly 700 unique supply chain ... 24X7 global event monitoring and alert reporting service. Supply ... trial period of the email service to receive early ... negatively impact revenue, market share, customer satisfaction, and shareholder ...
(Date:3/2/2015)... March 2, 2015 VLP Therapeutics, LLC. ... company focusing on the research and development of ... agents based upon a novel and proprietary vaccine ... Sciences Impact Grant Award from the Montgomery County ... by MCDED, is awarded to life sciences companies ...
(Date:3/2/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... therapeutics, today announced that it will be presenting ... FL at the Loews Miami Beach Hotel.  Dr. ... will provide an overview of the company,s development ... A live audio webcast and archive of the ...
Breaking Biology Technology:Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2
... Biotest Pharmaceuticals,Corporation, a leading developer of ... management team as part of the formal,completion ... (Nasdaq:,NABI) and the creation of Biotest Pharmaceuticals. ... Corporation Completes Acquisition,of Nabi Biologics Business Unit," ...
... Biotest Pharmaceuticals,Corporation, a leading developer of immunology ... the acquisition of the Nabi,Biopharmaceuticals (Nasdaq: ... million,in cash. Biotest Pharmaceuticals is a wholly-owned ... of the Nabi Biologics product pipeline,(including Nabi-HB(R)), ...
... Provide Testing for Important Cancer and Leukemia Group ... ... Genetics,a business unit of Genzyme Corporation (Nasdaq: GENZ ), announced today ... National Cancer Institute. The multi-center study will include 1,700,newly diagnosed patients with ...
Cached Biology Technology:Biotest Pharmaceuticals Corporation Announces Management Team 2Biotest Pharmaceuticals Corporation Announces Management Team 3Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 2National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 4
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... MADISON, Wis. Transplantation of human stem cells in ... survival and muscle function in rats used to model ... muscles, causing death by respiratory failure. ALS (amyotrophic ... to the ALS Association, the condition strikes about 5,600 ...
... (May 27, 2013) A new study shows the ... significant spike in the number of young children treated ... "We have seen an increase in unintentional ingestions ... laws in Colorado," said George Wang, MD, lead author ...
... College researchers have identified a new regulator for plant hormone ... that may help to improve production of fruits, vegetables ... week of May 27 in the journal Proceedings of ... paper, titled "SCFKMD controls cytokinin signaling by regulating the degradation ...
Cached Biology News:Engineered stem cell advance points toward treatment for ALS 2Engineered stem cell advance points toward treatment for ALS 3Surge in children accidentally eating marijuana-laced foods 2Surge in children accidentally eating marijuana-laced foods 3KISS ME DEADLY proteins may help improve crop yields 2
... Anti-NY-ESO-1, clone E978 ... NM_001327 Immunogen : ... Formulation: mouse ascites with ... Assurance: routinely evaluated by ...
R26.4C...
Form: Ready to use Applications: ELISA...
... rotary tables offer precision motorized rotation and ... with Parkers linear positioners and its low ... configurations., , Preloaded, precision worm gear ... race preloaded angular contact support bearing , ...
Biology Products: